Khushboo Begwani

Employment

Employment history is unavailable.

Education

• KM Kundnani College of Pharmacy Masters of Pharmacy
  2015 - 2017
• KM Kundnani College of Pharmacy Bachelor's of Pharmacy
  2011 - 2015

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Synthesis and biological evaluation of benzamide‐chalcone hybrids as potential c‐Met kinase and COX‐2 inhibitors
  Archiv der Pharmazie 2023 DOI: 10.1002/ardp.202200405
  +Save
• Evaluation of Benzamide-Chalcone Derivatives as EGFR/CDK2 Inhibitor: Synthesis, In-Vitro Inhibition, and Molecular Modeling Studies
  Anti-Cancer Agents in Medicinal Chemistry 2022 DOI: 10.2174/1871520621666210415091359
  +Save
• Cinnamamide-chalcone derivatives as CDK2 inhibitors: synthesis, pharmacological evaluation, and molecular modelling study
  Journal of the Iranian Chemical Society 2022 DOI: 10.1007/s13738-022-02610-y
  +Save
• Novel substituted 5-arylidene-1, 3-thiazolidin-4-one analogues: Synthesis, optimization, anticancer screening and docking studies
  Journal of Pharmaceutical Negative Results 2022 DOI: 10.47750/pnr.2022.13.S06.310
  +Save
• Cinnamamide-Chalcone Derivatives as CDK2 Inhibitors: Synthesis, Pharmacological Evaluation, and Molecular Modelling Study
  2021 DOI: 10.21203/rs.3.rs-528960/v1
  +Save
• Cinnamamide-Chalcone Derivatives as CDK2 Inhibitors: Synthesis, Pharmacological Evaluation, and Molecular Modelling Study
  ResearchSquare 2021 DOI: 10.21203/rs.3.rs-528960
  +Save
• Studies in molecular modeling, in-vitro CDK2 inhibition and antimetastatic activity of some synthetic flavones
  Frontiers in Bioscience 2021 DOI: 10.2741/4911
  +Save